Skip to main content
. 2006 Jan;143(1):125–131. doi: 10.1111/j.1365-2249.2005.02960.x

Fig. 2.

Fig. 2

Comparison of serum concentrations of interleukin (IL)-6, soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in patients with inflammatory bowel disease before and after successful treatment. Paired serum samples were obtained from six patients with ulcerative colitis (a, UC) and seven with Crohn's disease (b, CD) during active phase and just after the resolution of disease exacerbation.